C07K 14/5403
Il-3
Official title: {il-3}
C07K14/5403 (Il-3) appears on 153 US grants and 120 published applications in this corpus.
Search patents in C07K- Granted patents
- 153
- Published applications
- 120
- Assignees
- 65
- Inventors
- 227
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 7 | 0 |
| 1996 | 7 | 0 |
| 1997 | 11 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 14 | 0 |
| 2001 | 4 | 0 |
| 2002 | 12 | 3 |
| 2003 | 3 | 9 |
| 2004 | 2 | 10 |
| 2005 | 2 | 10 |
| 2006 | 3 | 2 |
| 2007 | 6 | 2 |
| 2008 | 6 | 4 |
| 2009 | 1 | 5 |
| 2010 | 3 | 2 |
| 2011 | 3 | 3 |
| 2012 | 0 | 1 |
| 2013 | 3 | 4 |
| 2014 | 2 | 3 |
| 2015 | 1 | 5 |
| 2016 | 1 | 3 |
| 2017 | 4 | 2 |
| 2018 | 4 | 5 |
| 2019 | 6 | 8 |
| 2020 | 2 | 4 |
| 2021 | 4 | 7 |
| 2022 | 3 | 4 |
| 2023 | 2 | 4 |
| 2024 | 3 | 8 |
| 2025 | 4 | 5 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Leucine zipper-based compositions and methods of use30 Dec 2025US 12,509,498 B2Memorial Sloan Kettering Cancer Center
- Methods and models for assessing efficacy of immunotherapies9 Sep 2025US 12,409,237 B1The Jackson Laboratory
- Genetically modified mice and engraftment2 Sep 2025US 12,402,611 B2Regeneron Pharmaceuticals, Inc.
- Combination therapy method of treating myeloproliferative neoplasms with a diphtheria toxin-human interleukin-3 conjugate in combination with other agents15 Jul 2025US 12,357,700 B2Stemline Therapeutics, Inc.
- Methods and compositions for treating cancer1 Oct 2026US 2026/0297152 A1
- Multi-receptor natural killer cells17 Sep 2026US 2026/0275288 A1Board of Regents, The University of Texas System
- Humanized immunodeficient mouse models26 Mar 2026US 2026/0083106 A1The Jackson Laboratory
- Genetically Modified Mice and Engraftment5 Mar 2026US 2026/0060222 A1Institute for Research in Biomedicine (IRB)
- Methods and models for assessing efficacy of immunotherapies5 Feb 2026US 2026/0033467 A1The Jackson Laboratory
Most cited
By later US patents
- Site-specific homogeneous modification of polypeptides317US 4,904,584 AGenetics Institute, Inc. · 1990
- Fusion proteins comprising GM-CSF and IL-3245US 5,073,627 AImmunex Corporation · 1991
- Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells210US 5,437,994 AThe Regents of the University of Michigan · 1995
- Cysteine added variants of interleukin-3 and chemical modifications thereof202US 5,166,322 AGenetics Institute, Inc. · 1992
- Primate hematopoietic growth factors IL-3 and pharmaceutical compositions195US 4,959,455 AGenetics Institute, Inc. · 1990